The Concept of CMR

Epidemiology

Abdominal Obesity and CVD

References

Page: Go to Previous Page 10 of 10 Go to Next Page
  1. Bray GA, Bouchard C and James WPT, eds. Handbook of obesity. New York: Marcel Dekker. 1998.
  2. Poirier P and Després JP. Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 2003; 23: 161-9.
  3. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997; 96: 3248-50.
  4. Eckel RH and Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998; 97: 2099-100.
  5. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26- year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-77.
  6. Keys A, Aravanis C, Blackburn H, et al. Coronary heart disease: overweight and obesity as risk factors. Ann Intern Med 1972; 77: 15-27.
  7. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-9.
  8. Reed D and Yano K. Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program. Comparisons of cohort and arteriography series analyses. Am J Epidemiol 1991; 134: 111-22.
  9. Freedman DS, Williamson DF, Croft JB, et al. Relation of body fat distribution to ischemic heart disease. The National Health and Nutrition Examination Survey I (NHANES I) Epidemiologic Follow-up Study. Am J Epidemiol 1995; 142: 53-63.
  10. Fitzgerald AP and Jarrett RJ. Body weight and coronary heart disease mortality: an analysis in relation to age and smoking habit. 15 years follow-up data from the Whitehall Study. Int J Obes Relat Metab Disord 1992; 16: 119-23.
  11. Barrett-Connor EL. Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med 1985; 103: 1010-9.
  12. Duflou J, Virmani R, Rabin I, et al. Sudden death as a result of heart disease in morbid obesity. Am Heart J 1995; 130: 306-13.
  13. Bharati S and Lev M. Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 1995; 129: 273-81.
  14. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group. J Chronic Dis 1978; 31: 201-306.
  15. Bray GA, Davidson MB and Drenick EJ. Obesity: a serious symptom. Ann Intern Med 1972; 77: 779-95.
  16. Després JP, Lemieux I and Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001; 322: 716-20.
  17. Vague J. La différenciation sexuelle: facteur déterminant des formes de l'obesité. Presse Med 1947; 339-40.
  18. Terry RB, Stefanick ML, Haskell WL, et al. Contributions of regional adipose tissue depots tp plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism 1991; 40: 733-40.
  19. Pouliot MC, Després JP, Nadeau A, et al. Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women. Int J Obes 1990; 14: 293-302.
  20. Lapidus L, Bengtsson C, Larsson BO, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweaden. BMJ 1984; 289: 1261-3.
  21. Larsson B, Svardsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. BMJ (Clin Res Ed) 1984; 288: 1401-4.
  22. Donahue RP, Abbott RD, Bloom E, et al. Central obesity and coronary heart disease in men. Lancet 1987; 1: 821-4.
  23. Ducimetiere P, Richard J and Cambien F. The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes 1986; 10: 229-40.
  24. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2: 51S-209S.
  25. Garrow J and Summerbell C. Meta-analysis on the effect of exercise on the composition of weight loss. Int J Obes Relat Metab Disord 1994; 18: 516-7.
  26. Kissebah AH, Freedman DS and Peiris AN. Health risks of obesity. Med Clin North Am 1989; 73: 111-38.
  27. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72.
  28. Wannamethee SG, Shaper AG, Walker M, et al. Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middle-aged British men. Arch Intern Med 1998; 158: 2433-40.
  29. Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1-7.
  30. Dagenais GR, Yi Q, Mann JF, et al. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005; 149: 54-60.
  31. Folsom AR, Stevens J, Schreiner PJ, et al. Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Atherosclerosis Risk in Communities Study Investigators. Am J Epidemiol 1998; 148: 1187-94.
  32. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-8.
  33. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
  34. Kuk JL, Katzmarzyk PT, Nichaman MZ, et al. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 2006; 14: 336-41.
  35. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-84.
  36. Ruderman NB, Schneider SH and Berchtold P. The "metabolically-obese," normal-weight individual. Am J Clin Nutr 1981; 34: 1617-21.
  37. Ruderman NB, Berchtold P and Schneider S. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 1982; 6 Suppl 1: 151-7.
  38. Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
  39. Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100: 1166-73.
  40. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-9.
  41. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-12.
  42. St-Onge MP, Janssen I and Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004; 27: 2222-8.
  43. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-9.
  44. Després JP, Nadeau A, Tremblay A, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38: 304-9.
  45. Sparrow D, Borkan GA, Gerzof SG, et al. Relationship of fat distribution to glucose tolerance Results of computed tomography in male participants of the Normative Aging Study. Diabetes 1986; 35: 411-5.
  46. Ruderman N, Chisholm D, Pi-Sunyer X, et al. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.
  47. Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 1997; 13: 3-13.
  48. Després JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990; 10: 497-511.
  49. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-34.
  50. Ross R, Freeman J, Hudson R, et al. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002; 87: 5044-51.
  51. Ross R, Aru J, Freeman J, et al. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002; 282: E657-63.
  52. Després JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006; 38: 52-63.
Page: Go to Previous Page 10 of 10 Go to Next Page
Print this document